Medicare Price Negotiations: A Resource Guide

The Facts: Medicare Part D and Prescription Drug Prices

Source: A fact sheet jointly prepared by health policy experts from the American Enterprise Institute, the Center for Medicine in the Public Interest, the Galen Institute, The Heritage Foundation, the Institute for Policy Innovation, the Institute for Research on the Economics of Taxation, the National Center for Policy Analysis, and the Pacific Research Institute, 01/09/07

Full text: http://www.galen.org/pdrugs.asp?docID=958

 

 

 

 

 

Can Government Price Negotiation Work for the Medicare Drug Benefit?

American Enterprise Institute Event

Friday, January 19, 2007, 2:00 p.m. – 4:00 p.m.

Wohlstetter Conference Center, Twelfth Floor, AEI

1150 Seventeenth Street, NW, Washington, DC

Registration: www.aei.org

 

 

 

 

 

Medicare and the Market

Author: Mike Leavitt

Source: The Washington Post, 01/11/07

Full text: http://www.washingtonpost.com/wp-dyn/content/article/2007/01/10/AR2007011002020.html?sub=AR

 

 

 

 

 

Experts Fault House Bill on Medicare Drug Prices

Author: Christopher Lee

Source: The Washington Post, 01/11/07

Full text: http://www.washingtonpost.com/wp-dyn/content/article/2007/01/10/AR2007011002150.html

 

 

 

 

 

Hearing on Prescription Drug Pricing and Negotiation for the Medicare Prescription Drug Benefit

Author: Edmund F. Haislmaier, The Heritage Foundation

Source: U.S. Senate Committee on Finance, 01/11/07

Full text: http://www.heritage.org

 

 

 

 

 

The Fix is In

Author: Sally Pipes

Source: National Review Online, 01/11/07

Full text: http://www.pacificresearch.org/press/opd/2007/opd_07-01-11sp.html

 

 

 

 

 

We Oppose Negotiations on Medicare Part D Drug Prices

Source: The Hill, 01/10/07

Full text: http://thehill.com

 

 

Medicare Part D ? How Would the Government Negotiate?

Author: Senator Charles Grassley

Source: U.S. Senate Committee on Finance, 01/10/07

Full text: http://finance.senate.gov/press/Gpress/2007/prg010907d.pdf

 

 

 

 

 

Drug Program Enrollment Increases

Author: Kevin Freking

Source: Houston Chronicle, 01/10/07

Full text: http://www.chron.com/disp/story.mpl/ap/politics/4461603.html

 

 

 

 

 

H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007

Source: Congressional Budget Office, 01/10/07

Full text: http://www.cbo.gov/showdoc.cfm?index=7722&sequence=0&from=7

 

 

 

 

 

What's Wrong with Negotiations?

Author: Grace-Marie Turner

Source: Galen Institute, 01/08/07

Full text: http://www.galen.org/pdrugs.asp?docID=961

 

 

 

 

Reference Pricing without the Reference

Author: Peter Pitts

Source: Center for Medicine in the Public Interest/DrugWonks.com

Full text: http://www.drugwonks.com

 

 

 

 

 

 

No Way VA is a Better Way

Author: Peter Pitts

Source: Center for Medicine in the Public Interest

Full text: http://www.galen.org/pdrugs_cg.asp?docID=962

 

 

 

 

 

Federal Drug Price Negotiation: Implications for Medicare Part D

Author: Jim Hahn

Source: Congressional Research Service, 01/05/07

Full text: /assets/CRSRL33782.pdf

 

 

 

 

The Wrong Prescription for Medicare Drug Plan

Author: Yong Suh

Source: The Baltimore Sun, 01/05/07

Full text: http://www.baltimoresun.com/news/opinion/oped/bal-op.medicare05jan05,0,5237416.story?coll=bal-oped-headlines

 

 

 

 

 

Medicare Drug Benefit Fine As Is, Madam Speaker

Author: Grace-Marie Turner

Source: Houston Chronicle, 01/04/07

Full text: http://www.chron.com/disp/story.mpl/editorial/outlook/4447256.html

 

 

 

 

 

Prescription Drug Costs

Author: Benjamin Zycher

Source: The Washington Times, 12/27/06

Full text: http://washingtontimes.com/op-ed/20061226-093747-6813r.htm

 

 

 

 

 

Should Medicare negotiate prices? No. Private insurers are already getting discounts

Author: Robert E. Moffit, Ph.D.

Source: Philadelphia Inquirer, 12/07/06

Full text: http://www.heritage.org/Press/Commentary/ed120706d.cfm

 

 

 

 

 

Why the New Congress Should Not Fix Drug Prices

Author: Greg D'Angelo

Source: The Heritage Foundation, 12/01/06

Full text: http://www.heritage.org/Research/HealthCare/wm1270.cfm

 

 

 

 

 

A Tale of Two Drug Classes Shows Why U.S. Mustn't Go Europe's Way

Author: Paul Howard

Source: Investor's Business Daily, 12/01/06

Full text: http://www.investors.com/editorial/editorialcontent.asp?secid=1502&status=article&id=249867258301472

 

 

 

 

 

The Human Cost of Federal Price Negotiations: The Medicare prescription drug benefit and pharmaceutical innovation

Author: Benjamin Zycher, Ph.D.

Source: Center for Medical Progress at the Manhattan Institute, 11/06

Full text: http://www.manhattan-institute.org/html/mpr_03.htm

 

 

 

 

 

On Drug Prices, Are Democrats in a Fix?

Author: Ricardo Alonso-Zaldivar

Source: Los Angeles Times, 11/26/06

Full text: http://www.latimes.com/news/nationworld/washingtondc/la-na-medicare26nov26,1,846605.story?ctrack=1&cset=true

 

 

 

 

 

Success of Drug Plan Challenges Democrats

Authors: Lori Montgomery and Christopher Lee

Source: The Washington Post, 11/26/06

Full text: http://www.washingtonpost.com/wp-dyn/content/article/2006/11/25/AR2006112500919.html?nav=rss_politics

 

 

 

 

 

A Drug Price Path to Avoid

Author: Alberto Mingardi

Source: The Washington Post, 11/12/06

Full text: http://www.washingtonpost.com/wp-dyn/content/article/2006/11/10/AR2006111001489.html

 

 

 

 

 

Should the U.S. Government be Prohibited from Negotiating with Drug Companies?

Guest: Peter Pitts

Source: The Bauer and Rose Show, 11/14/06

Listen online: http://www.bauerandrose.com/show?action=viewRadioShow&showID=518

 

 

 

 

 

Competition Works

Author: Grace-Marie Turner

Source: Galen Institute, 11/2/06

Full text: http://www.galen.org/medicare.asp?docID=933

 

 

 

 

 

 

The Dangers of Undermining Patient Choice:

Lessons from Europe and Canada

Source: Institute for Policy Innovation, Galen Institute, and International Policy Network, 10/06

Full text: http://www.galen.org/healthabroad.asp?docID=929

 

 

 

 

 

The Praises and Pitfalls of Part D

Author: Grace-Marie Turner

Source: The Kansas City Star, 10/29/06

Full text: http://www.galen.org/medicare.asp?docID=933

 

 

 

 

 

Medicare Part D: Improving Care for Beneficiaries Without Drug Coverage

Source: PhRMA, 10/27/06

Full text: http://www.phrma.org/news_room/press_releases/part_d_providing_lower_costs%2c_improved_access%2c_study_shows/

 

 

 

 

 

The Future of Medicare

Author: Robert Goldberg, Ph.D.

Source: The Washington Times, 10/17/06

Full text: http://www.washingtontimes.com/op-ed/20061016-100753-7317r.htm

 

 

 

 

 

Debunking Medicare Myths

Author: Grace-Marie Turner

Source: Galen Institute, 9/15/06

Full text: http://www.galen.org/medicare.asp?docID=920

 

 

 

 

 

Lawsuit Ignores Who?s Gouging Whom on Drug Prices

Author: John R. Graham

Source: Pacific Research Institute, 09/02/05

Full text: http://www.pacificresearch.org/press/opd/2005/opd_05-09-02jg.html

 

 

SHARE THIS ARTICLE

About the author

The Facts: Medicare Part D and Prescription Drug Prices

Source: A fact sheet jointly prepared by health policy experts from the American Enterprise Institute, the Center for Medicine in the Public Interest, the Galen Institute, The Heritage Foundation, the Institute for Policy Innovation, the Institute for Research on the Economics of Taxation, the National Center for Policy Analysis, and the Pacific Research Institute, 01/09/07

Full text: http://www.galen.org/pdrugs.asp?docID=958

 

 

 

 

 

Can Government Price Negotiation Work for the Medicare Drug Benefit?

American Enterprise Institute Event

Friday, January 19, 2007, 2:00 p.m. – 4:00 p.m.

Wohlstetter Conference Center, Twelfth Floor, AEI

1150 Seventeenth Street, NW, Washington, DC

Registration: www.aei.org

 

 

 

 

 

Medicare and the Market

Author: Mike Leavitt

Source: The Washington Post, 01/11/07

Full text: http://www.washingtonpost.com/wp-dyn/content/article/2007/01/10/AR2007011002020.html?sub=AR

 

 

 

 

 

Experts Fault House Bill on Medicare Drug Prices

Author: Christopher Lee

Source: The Washington Post, 01/11/07

Full text: http://www.washingtonpost.com/wp-dyn/content/article/2007/01/10/AR2007011002150.html

 

 

 

 

 

Hearing on Prescription Drug Pricing and Negotiation for the Medicare Prescription Drug Benefit

Author: Edmund F. Haislmaier, The Heritage Foundation

Source: U.S. Senate Committee on Finance, 01/11/07

Full text: http://www.heritage.org

 

 

 

 

 

The Fix is In

Author: Sally Pipes

Source: National Review Online, 01/11/07

Full text: http://www.pacificresearch.org/press/opd/2007/opd_07-01-11sp.html

 

 

 

 

 

We Oppose Negotiations on Medicare Part D Drug Prices

Source: The Hill, 01/10/07

Full text: http://thehill.com

 

 

Medicare Part D ? How Would the Government Negotiate?

Author: Senator Charles Grassley

Source: U.S. Senate Committee on Finance, 01/10/07

Full text: http://finance.senate.gov/press/Gpress/2007/prg010907d.pdf

 

 

 

 

 

Drug Program Enrollment Increases

Author: Kevin Freking

Source: Houston Chronicle, 01/10/07

Full text: http://www.chron.com/disp/story.mpl/ap/politics/4461603.html

 

 

 

 

 

H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007

Source: Congressional Budget Office, 01/10/07

Full text: http://www.cbo.gov/showdoc.cfm?index=7722&sequence=0&from=7

 

 

 

 

 

What's Wrong with Negotiations?

Author: Grace-Marie Turner

Source: Galen Institute, 01/08/07

Full text: http://www.galen.org/pdrugs.asp?docID=961

 

 

 

 

Reference Pricing without the Reference

Author: Peter Pitts

Source: Center for Medicine in the Public Interest/DrugWonks.com

Full text: http://www.drugwonks.com

 

 

 

 

 

 

No Way VA is a Better Way

Author: Peter Pitts

Source: Center for Medicine in the Public Interest

Full text: http://www.galen.org/pdrugs_cg.asp?docID=962

 

 

 

 

 

Federal Drug Price Negotiation: Implications for Medicare Part D

Author: Jim Hahn

Source: Congressional Research Service, 01/05/07

Full text: /assets/CRSRL33782.pdf

 

 

 

 

The Wrong Prescription for Medicare Drug Plan

Author: Yong Suh

Source: The Baltimore Sun, 01/05/07

Full text: http://www.baltimoresun.com/news/opinion/oped/bal-op.medicare05jan05,0,5237416.story?coll=bal-oped-headlines

 

 

 

 

 

Medicare Drug Benefit Fine As Is, Madam Speaker

Author: Grace-Marie Turner

Source: Houston Chronicle, 01/04/07

Full text: http://www.chron.com/disp/story.mpl/editorial/outlook/4447256.html

 

 

 

 

 

Prescription Drug Costs

Author: Benjamin Zycher

Source: The Washington Times, 12/27/06

Full text: http://washingtontimes.com/op-ed/20061226-093747-6813r.htm

 

 

 

 

 

Should Medicare negotiate prices? No. Private insurers are already getting discounts

Author: Robert E. Moffit, Ph.D.

Source: Philadelphia Inquirer, 12/07/06

Full text: http://www.heritage.org/Press/Commentary/ed120706d.cfm

 

 

 

 

 

Why the New Congress Should Not Fix Drug Prices

Author: Greg D'Angelo

Source: The Heritage Foundation, 12/01/06

Full text: http://www.heritage.org/Research/HealthCare/wm1270.cfm

 

 

 

 

 

A Tale of Two Drug Classes Shows Why U.S. Mustn't Go Europe's Way

Author: Paul Howard

Source: Investor's Business Daily, 12/01/06

Full text: http://www.investors.com/editorial/editorialcontent.asp?secid=1502&status=article&id=249867258301472

 

 

 

 

 

The Human Cost of Federal Price Negotiations: The Medicare prescription drug benefit and pharmaceutical innovation

Author: Benjamin Zycher, Ph.D.

Source: Center for Medical Progress at the Manhattan Institute, 11/06

Full text: http://www.manhattan-institute.org/html/mpr_03.htm

 

 

 

 

 

On Drug Prices, Are Democrats in a Fix?

Author: Ricardo Alonso-Zaldivar

Source: Los Angeles Times, 11/26/06

Full text: http://www.latimes.com/news/nationworld/washingtondc/la-na-medicare26nov26,1,846605.story?ctrack=1&cset=true

 

 

 

 

 

Success of Drug Plan Challenges Democrats

Authors: Lori Montgomery and Christopher Lee

Source: The Washington Post, 11/26/06

Full text: http://www.washingtonpost.com/wp-dyn/content/article/2006/11/25/AR2006112500919.html?nav=rss_politics

 

 

 

 

 

A Drug Price Path to Avoid

Author: Alberto Mingardi

Source: The Washington Post, 11/12/06

Full text: http://www.washingtonpost.com/wp-dyn/content/article/2006/11/10/AR2006111001489.html

 

 

 

 

 

Should the U.S. Government be Prohibited from Negotiating with Drug Companies?

Guest: Peter Pitts

Source: The Bauer and Rose Show, 11/14/06

Listen online: http://www.bauerandrose.com/show?action=viewRadioShow&showID=518

 

 

 

 

 

Competition Works

Author: Grace-Marie Turner

Source: Galen Institute, 11/2/06

Full text: http://www.galen.org/medicare.asp?docID=933

 

 

 

 

 

 

The Dangers of Undermining Patient Choice:

Lessons from Europe and Canada

Source: Institute for Policy Innovation, Galen Institute, and International Policy Network, 10/06

Full text: http://www.galen.org/healthabroad.asp?docID=929

 

 

 

 

 

The Praises and Pitfalls of Part D

Author: Grace-Marie Turner

Source: The Kansas City Star, 10/29/06

Full text: http://www.galen.org/medicare.asp?docID=933

 

 

 

 

 

Medicare Part D: Improving Care for Beneficiaries Without Drug Coverage

Source: PhRMA, 10/27/06

Full text: http://www.phrma.org/news_room/press_releases/part_d_providing_lower_costs%2c_improved_access%2c_study_shows/

 

 

 

 

 

The Future of Medicare

Author: Robert Goldberg, Ph.D.

Source: The Washington Times, 10/17/06

Full text: http://www.washingtontimes.com/op-ed/20061016-100753-7317r.htm

 

 

 

 

 

Debunking Medicare Myths

Author: Grace-Marie Turner

Source: Galen Institute, 9/15/06

Full text: http://www.galen.org/medicare.asp?docID=920

 

 

 

 

 

Lawsuit Ignores Who?s Gouging Whom on Drug Prices

Author: John R. Graham

Source: Pacific Research Institute, 09/02/05

Full text: http://www.pacificresearch.org/press/opd/2005/opd_05-09-02jg.html

 

 

SHARE THIS ARTICLE

About the author